Investigational Lotion QRX003 Shows Early Promise in Netherton Syndrome Case
A 21-month compassionate-use case report describes the first pediatric use of the investigational topical lotion QRX003 in Netherton syndrome, with ...
Tag: QRX003
POPULAR NEWS
-
Generative AI Enters Early Childhood Assessment Faster Than Research Can Follow
-
Nearly Half of Patients with Behçet’s Disease Report Depression or Anxiety
-
Subcutaneous Infliximab Could Cut Jordan’s Autoimmune Disease Treatment Costs
-
Platform Trials Promise Faster Answers but Face Serious Methodological Pitfalls